The Contribution of a Third Autologous Stem Cell Transplant in the Era of Novel Agents: Favourable Overall Survival and Improvement of Exhausted Bone Marrow Function von Strifler, S, Hilgendorf, I, Kleber, M, Röllig, C, Mügge, L.O, Teleanu, V, Danhof, S, Schreder, M, Einsele, H, Knop, S

Volltext

Influence of CRBN, IKZF1, and IKZF3 expression on outcome in lenalidomide treated newly diagnosed multiple myeloma patients von Krönke, J, Kuchenbauer, F, Kull, M, Teleanu, V, Bullinger, L, Greiner, A, Kolmus, S, Köpff, S, Mügge, L.O, Straka, C, Bassermann, F, Engelhardt, M, Bargou, R, Einsele, H, Langer, C, Knop, S

Volltext

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial von Bahlis, Nizar J, Corso, A, Mugge, L.O, Shen, Z.X, Desjardins, Pierre, Stoppa, A.M, Decaux, O, De Revel, T, Granell, Miquel, Marit, G, Nahi, Hareth, Demuynck, H, Huang, S.Y, Basu, S, Guthrie, T.H, Ervin-Haynes, A, Marek, J, Chen, G, Facon, Thierry, Universitat Autònoma de Barcelona

Volltext bestellen